click below
click below
Normal Size Small Size show me how
BDK Musculoskeletal
Basic Drug Knowledge Musculoskeletal
| Generic Name | Brand Name | Classification | Pharmacologic Category | Common Indications | Key Side Effects | US Boxed Warnings | US Boxed Warnings Cont. | Other Notes |
|---|---|---|---|---|---|---|---|---|
| Tizanidine (PO) | Zanaflex | Alpha 2 Agonist | Spasticity | Drowsiness, Hypotension, Dizziness, Xerostomia, Weakness | ||||
| Hydroxychloroquine (PO) | Plaquenil | Aminoquinolone | Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Malaria | Retinal Toxicity, Rash, Diarrhea | Long-term use has been associated with cardiomyopathy, Bone marrow suppression, QT prolongation, & Neuromuscular effects (i.e., Myopathy, Palsies, & Progressive weakness) | |||
| Diclofenac (Topical) | Voltaren Gel | OTC | Non-Steroidal Anti-Inflammatory Drug (NSAID) | Osteoarthritis (OA) | Pruritus, Rash | |||
| Diclofenac (PO) | Voltaren | Non-Steroidal Anti-Inflammatory Drug (NSAID) | Osteoarthritis (OA), Rheumatoid Arthritis (RA), Acute Pain | Diarrhea, Dyspepsia, Abdominal Pain, Flatulence, Nausea | May increase the risk of serious (& potentially fatal) cardiovascular thrombotic events, MI (Myocardial Infarction), & Stroke; May increase the risk for serious (& potentially fatal) GI adverse events including ulceration, bleeding, & perforation | May reduce renal blood flow & compromise existing renal function (Avoid in patients with renal disease, heart failure, & cirrhosis) | ||
| Ibuprofen (PO) | Motrin, Advil | OTC | Non-Steroidal Anti-Inflammatory Drug (NSAID) | Osteoarthritis (OA), Rheumatoid Arthritis (RA), Acute Pain | Diarrhea, Dyspepsia, Abdominal Pain, Flatulence, Nausea | May increase the risk of serious (& potentially fatal) cardiovascular thrombotic events, MI (Myocardial Infarction), & Stroke; May increase the risk for serious (& potentially fatal) GI adverse events including ulceration, bleeding, & perforation | May reduce renal blood flow & compromise existing renal function (Avoid in patients with renal disease, heart failure, & cirrhosis) | |
| Meloxicam (PO) | Mobic | Non-Steroidal Anti-Inflammatory Drug (NSAID) | Osteoarthritis (OA), Rheumatoid Arthritis (RA), Acute Pain | Diarrhea, Dyspepsia, Abdominal Pain, Flatulence, Nausea | May increase the risk of serious (& potentially fatal) cardiovascular thrombotic events, MI (Myocardial Infarction), & Stroke; May increase the risk for serious (& potentially fatal) GI adverse events including ulceration, bleeding, & perforation | May reduce renal blood flow & compromise existing renal function (Avoid in patients with renal disease, heart failure, & cirrhosis) | ||
| Indomethacin (PO) | Indocin | Non-Steroidal Anti-Inflammatory Drug (NSAID) | Osteoarthritis (OA), Rheumatoid Arthritis (RA), Acute Pain, Gout | Diarrhea, Dyspepsia, Abdominal Pain, Flatulence, Nausea | May increase the risk of serious (& potentially fatal) cardiovascular thrombotic events, MI (Myocardial Infarction), & Stroke; May increase the risk for serious (& potentially fatal) GI adverse events including ulceration, bleeding, & perforation | May reduce renal blood flow & compromise existing renal function (Avoid in patients with renal disease, heart failure, & cirrhosis) | ||
| Naproxen (PO) | Naprosyn, Anaprox, Aleve | OTC | Non-Steroidal Anti-Inflammatory Drug (NSAID) | Osteoarthritis (OA), Rheumatoid Arthritis (RA), Acute Pain, Gout | Diarrhea, Dyspepsia, Abdominal Pain, Flatulence, Nausea | May increase the risk of serious (& potentially fatal) cardiovascular thrombotic events, MI (Myocardial Infarction), & Stroke; May increase the risk for serious (& potentially fatal) GI adverse events including ulceration, bleeding, & perforation | May reduce renal blood flow & compromise existing renal function (Avoid in patients with renal disease, heart failure, & cirrhosis) | |
| Ketorolac (PO, IV) | Toradol | Non-Steroidal Anti-Inflammatory Drug (NSAID) | Pain | Diarrhea, Dyspepsia, Abdominal Pain, Flatulence, Nausea | May increase the risk of serious (& potentially fatal) cardiovascular thrombotic events, MI (Myocardial Infarction), & Stroke; May increase the risk for serious (& potentially fatal) GI adverse events including ulceration, bleeding, & perforation | Indicated for short term use (≤ 5 days) | May reduce renal blood flow & compromise existing renal function (Avoid in patients with renal disease, heart failure, & cirrhosis) | |
| Celecoxib (PO) | Celebrex | Non-Steroidal Anti-Inflammatory Drug (NSAID), COX-2 Selective | Osteoarthritis (OA), Rheumatoid Arthritis (RA), Acute Pain | Diarrhea, Dyspepsia, Abdominal Pain, Flatulence, Nausea | May increase the risk of serious (& potentially fatal) cardiovascular thrombotic events, MI (Myocardial Infarction), & Stroke; May increase the risk for serious (& potentially fatal) GI adverse events including ulceration, bleeding, & perforation | May reduce renal blood flow & compromise existing renal function (Avoid in patients with renal disease, heart failure, & cirrhosis) | ||
| Cyclobenzaprine (PO) | Flexeril, Amrix, Fexmid | Skeletal Muscle Relaxant | Muscle Spasm | Drowsiness, Dizziness, Xerostomia, Fatigue | Use may cause prolonged cardiac arrhythmias, & tachycardia; CI within 14 days of MAOI (Monoamine Oxidase Inhibitor) therapy | |||
| Baclofen (PO) | --- | Skeletal Muscle Relaxant | Spasticity | Drowsiness | ||||
| Methocarbamol (PO) | Robaxin | Skeletal Muscle Relaxant | Muscle Spasm | Drowsiness | ||||
| Lidocaine (Transdermal, IV) | Transdermal: Lidoderm, IV: Xylocaine | Transdermal: OTC | Transdermal: Topical Analgesic IV: Antiarrhythmic | Transdermal: Pain, IV: Ventricular Arrhythmias | Transdermal: Dermatitis, Erythema, Urticaria, Skin Depigmentation, Skin Edema IV: Bradycardia | Patch may remain in place for up to 12 hours in any 24-hour period, Patch may be cut | ||
| Colchicine (PO) | Colcrys | Antigout Agent | Gout | Diarrhea, Nausea, Vomiting, Bone Marrow Suppression, Myopathy (including Rhabdomyolysis) | ||||
| Allopurinol (PO) | Zyloprim | Xanthine Oxidase Inhibitor | Gout | Diarrhea, Nausea, Rash, Leukopenia, Thrombocytopenia | Rare association with severe (& potentially fatal) allopurinol hypersensitivity syndrome (Risk highest in certain Asian populations) | |||
| Succinylcholine (IV) | Anectine | Depolarizing Neuromuscular Blocking Agent | Neuromuscular Blockade for Intubation or Procedures | Hyperkalemia, Myalgia, Malignant Hyperthermia (Rare) | Acute rhabdomyolysis & hyperkalemia leading to cardiac arrest & death in pediatric patients with undiagnosed skeletal muscle disease | |||
| Etanercept (SQ) | Enbrel | Anti-Tumor Necrosis Factor Alpha Inhibitor | Rheumatoid Arthritis (RA) | Infection, Injection Site Reaction, Headache, Nausea | Serious Infections, Malignancies such as Lymphoma | |||
| Adalimumab (SQ) | Humira | Anti-Tumor Necrosis Factor Alpha Inhibitor | Rheumatoid Arthritis (RA), Crohn's Disease, Ulcerative Colitis | Infection, Injection Site Reaction, Headache, Nausea | Serious Infections, Malignancies such as Lymphoma |